Niva Bupa Health Insurance Company (NIVABUPA) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
17 Apr, 2026Executive summary
Nine-month overall growth rate reached 26%, with retail growth at 33% and PAT at INR 208 crore; GWP for 9M'FY2026 was ₹6,309 crore, up 25.9% year-over-year, and IFRS PAT rose from ₹120 crore to ₹208 crore.
Retail Health market share improved to 10.0% for the nine months, with a renewal rate of 91.8% and a Weighted Episodal NPS of 58.
Recognized as a top workplace for six consecutive years and awarded Best Insurance Campaign at FICCI Insurance Industry Awards.
Unaudited standalone financial results for the quarter and nine months ended December 31, 2025, were approved by the Board and reviewed by joint statutory auditors, who issued an unmodified conclusion.
The company completed its IPO in November 2024, raising ₹80,000 lakhs, fully utilized by December 31, 2025, to augment capital and maintain solvency.
Financial highlights
Profit after tax (PAT) for nine months increased 74% year-over-year to INR 208 crore; Q3 PAT was INR 77 crore, up from INR 60 crore; GWP for 9M'FY2026 was ₹6,309 crore, up 25.9% year-over-year.
Combined ratio for nine months improved by 50 bps to 102.9% (102.6% excluding one-off wage code impact); CISR improved to 102.9% from 103.4% year-over-year.
Retail loss ratio for nine months at 66.9%, slightly better than last year’s 67%; Claims Settlement Ratio increased to 94.4% for 9M'FY2026.
Expense of management (EOM) ratio improved to 35% from 39% year-over-year; EOM as % of GWP at 35.0% for 9M'FY2026.
Annualized investment yield at 7.3% with AUM of INR 9,000 crore; AUM grew to ₹8,927 crore; solvency ratio at 2.49.
Outlook and guidance
Confident in meeting regulatory requirements for EOM and solvency for the full year; adhering to a regulatory glide path to bring EOM within prescribed limits by FY 2025-26.
GST tailwinds and industry initiatives expected to provide sustained growth, not just a one-off benefit; structural reforms and GST exemption on retail life & health insurance expected to accelerate market penetration.
Multi-year industry efforts on claims and cost control expected to yield gradual improvements.
Financial results for the quarters are not indicative of full-year performance due to industry seasonality.
Indian economy projected to grow by 7.4% in FY2026, supporting continued insurance sector expansion.
Latest events from Niva Bupa Health Insurance Company
- Premiums and profits surged, solvency strong, retail health share up, IPO completed.NIVABUPA
Q3 24/253 Feb 2026 - Premiums up over 33%, IFRS profit doubled, but Q2 FY26 saw a net loss amid regulatory changes.NIVABUPA
Q2 24/2512 Jan 2026 - GWP up 32%, PAT up 161%, retail share at 9.4%, AUM at INR 8,175 crores, EOM action ongoing.NIVABUPA
Q4 24/256 Jan 2026 - GWP up 28% YoY, IFRS PAT doubled, and combined ratio improved under IFRS.NIVABUPA
Q1 25/266 Jan 2026 - Net loss of ₹9,144 lakhs on 11.46% premium growth, with high combined ratio and regulatory risks.NIVABUPA
Q1 24/2520 Nov 2025 - H1 FY26 saw 23% GWP growth, doubled PAT, and GST cut drove a surge in retail demand.NIVABUPA
Q2 25/2613 Nov 2025